Satralizumab as a treatment for pediatric-onset neuromyelitis optica spectrum disorder with cluster attack: a case report. Wang R, Sun D, Du Q, Shi Z, et al. J Neurol 2023;270:5085-5089.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang R, Sun D, Du Q, Shi Z, et al. Satralizumab as a treatment for pediatric-onset neuromyelitis optica spectrum disorder with cluster attack: a case report. J Neurol 2023;270:5085-5089.
PMID: 37204456